Most Read Articles
Roshini Claire Anthony, 27 Jun 2019

A 2-week course of the immunotherapy drug teplizumab delayed the onset of type 1 diabetes (T1D) in individuals at high risk for the condition, according to a phase II trial conducted by the TrialNet Study Group and presented at ADA 2019.

Children with psoriasis at increased risk of obesity

01 Oct 2016

Higher waist-to-height ratio (WtHR) was more common in patients with psoriasis than in controls, suggesting that WtHR may be a better toll than body mass index (BMI) in identifying children at increased risk of greater central adiposity, suggests a study.

“WtHR can easily identify children with increased central adiposity and is a simpler alternative to BMI that does not require growth charts or percentiles,” researchers said. “Having a WtHR of 0.5 or greater is associated with future cardiovascular risk.”

A multicentre, cross-sectional, prospective case-control study was conducted to determine whether children with psoriasis are more likely to have increased WtHR, obesity, and metabolic syndrome compared with those without psoriasis. A total of 208 children (mean age 8.9 years; 110 girls) were involved, of which 135 had psoriasis and 73 were controls with noninflammatory skin conditions.

The primary outcomes were increased central adiposity indicated by WtHR ≥0.5, metabolic syndrome, and increased BMI.

Children with psoriasis relative to those without were more likely to have increased central adiposity, with WtHR ≥0.5 (29 vs 11 percent; p=0.002). Among children older than 10 years, 4 of 53 with psoriasis had metabolic syndrome compared with none of 29 in the control group (8 vs 0 percent; p=0.29). Metabolic syndrome was observed in 3 of 15 children with moderate to severe psoriasis compared with 1 of 38 children with mild psoriasis (20 vs 3 percent; p=0.6).

Children with moderate to severe psoriasis had a higher mean WtHR than children with mild psoriasis (0.48 vs 0.46; p=0.04). Overweight and obesity according to BMI did not vary significantly between children with psoriasis and controls (17 vs 16 percent; p=0.91).

The WtHR is a simple and valid tool to identify children with increased central adiposity. It has been shown to be associated with future cardiometabolic risk; it is easy to perform in children presenting with psoriasis; and we propose that it should be part of a standard workup,” researchers said.

“Children with psoriasis who are not overweight according to BMI are still more likely to have a WtHR of 0.5 or higher than children without psoriasis. This finding in a child with psoriasis is an opportunity to counsel the family about healthy lifestyle choices and is an opportunity for early intervention,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 27 Jun 2019

A 2-week course of the immunotherapy drug teplizumab delayed the onset of type 1 diabetes (T1D) in individuals at high risk for the condition, according to a phase II trial conducted by the TrialNet Study Group and presented at ADA 2019.